Q32 Bio (QTTB) Other Non-Current Liabilities (2023 - 2025)

Q32 Bio's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $55.0 million for Q3 2025.

• On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $55.0 million in Q3 2025; TTM through Sep 2025 was $55.0 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $55.0 million, changed 0.0% from the prior year.
• Other Non-Current Liabilities steadied at $55.0 million in Q3 2025 per QTTB's latest filing, from $55.0 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $55.1 million in Q1 2024 and bottomed at $55.0 million in Q4 2023.
• The 3-year median for Other Non-Current Liabilities is $55.0 million (2023), against an average of $55.0 million.
• Across the five-year window, Other Non-Current Liabilities changed 0.0% in 2024 and decreased 0.21% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
• Per Business Quant, the three latest QTTB Other Non-Current Liabilities figures stand at $55.0 million (Q3 2025), $55.0 million (Q2 2025), and $55.0 million (Q1 2025).